ProQR Q2 FY26 net loss narrows to EUR 8.7 million

Reuters2026/08/13 11:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

ProQR posted a Q2 net loss of EUR 8.7 million, narrowing from EUR 12.2 million a year earlier.
Loss per diluted share improved to EUR 0.08 from EUR 0.12 in the prior-year quarter.
R&D costs rose to EUR 12.7 million from EUR 11.4 million; general and administrative costs edged up to EUR 4.9 million from EUR 4.8 million.
Cash and cash equivalents totaled EUR 117.1 million at June 30, 2026; net cash used in operating activities was EUR 12.3 million.
Closed a $59.2 million financing; highlighted positive AX-0810 Phase 1 target engagement data, with full dataset slated for a conference later this year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-095422), on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

ProQR Q2 FY26 net loss narrows to EUR 8.7 million

You may also like

Crypto prices